An electronic pillbox intervention designed to improve medication safety during care transitions: challenges and lessons learned regarding implementation and evaluation

Amrita Shahani, Harry Reyes Nieva, Katie Czado, Evan Shannon, Raquel Gaetani, Marcus Gresham, Jose Cruz Garcia, Hareesh Ganesan, Emily Cerciello, Janan Dave, Rahul Jain, Jeffrey L Schnipper, Amrita Shahani, Harry Reyes Nieva, Katie Czado, Evan Shannon, Raquel Gaetani, Marcus Gresham, Jose Cruz Garcia, Hareesh Ganesan, Emily Cerciello, Janan Dave, Rahul Jain, Jeffrey L Schnipper

Abstract

Background: Adverse drug events are common during transitions of care. As part of the Smart Pillbox study, a cluster-randomized controlled trial of an electronic pillbox designed to reduce medication discrepancies and improve medication adherence after hospital discharge, we explored barriers to successful implementation and evaluation of this intervention.

Methods: Eligible patients were those admitted to a medicine service of a large teaching hospital with a plan to be discharged home on five or more chronic medications. The intervention consisted of an electronic pillbox with pre-filled weekly blister pack medication trays given to patients prior to discharge. Pillbox features included alarms to take medications, detection of pill removal from each well, alerts to patients or caregivers by phone, email, or text if medications were not taken, and adherence reports accessible by providers. Greater than 20% missed doses for three days in a row triggered outreach from a pharmacist. To identify barriers to implementation and evaluation of the intervention, we reviewed patient exit surveys, including quantitative data on satisfaction and free-text responses regarding their experiences; technical issue logs; and team meeting minutes. Themes were derived by consensus among the study authors and organized using the Consolidated Framework for Implementation Research.

Results: Barriers to implementation included intervention characteristics such as perceived portability issues with the pillbox and time required by pharmacists to enter medication information into the software; external policies such as lack of insurance coverage for early refills and regulatory prohibitions on repackaging medications; implementation climate issues such as the incompatibility between the rushed nature of hospital discharge with the time required to deploy the intervention; and patient issues such as denial of previous problems with medication adherence. We founds several obstacles to conducting the study, including patients declining study enrollment and limited attempts by the hospital to streamline logistics by building the intervention into usual care. Several solutions to address many of these challenges were implemented or planned. Despite these challenges, many patients with the pillbox were pleased with the service and believed the intervention worked well for them.

Conclusions: In this evaluation, several barriers to implementing and conducting a study of the effectiveness of the intervention were identified. Our findings provide lessons learned for others wishing to implement and evaluate HIT-related interventions designed to improve medication safety during care transitions.

Trial registration: Clinicaltrials.gov NCT03475030.

Keywords: Care transitions; Health information technology; Implementation science; Medication safety.

Conflict of interest statement

Hareesh Ganesan, BSE, Emily Cerciello, BS, Janan Dave, BS, and Rahul Jain, BS were employees of Towerview during the study period.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Smart pillbox. Top figure illustrates the closed pill box. Middle figure illustrates insertion of the blister pack into the pill box. Bottom figure illustrates a patient removing pills from one of the wells
Fig. 2
Fig. 2
Medication Adherence Reports. Top figure illustrates a sample adherence report (trend graph) by week. Bottom graph illustrates a “heat map” with number of doses removed and mean timing of removal for each administration day and time over the course of one month
Fig. 3
Fig. 3
Flow diagram of intervention patients. Abbreviations: HCP: healthcare proxy; PCP: primary care provider

References

    1. Coleman EA, Berenson RA. Lost in transition: challenges and opportunities for improving the quality of transitional care. Ann Intern Med. 2004;141(7):533–536. doi: 10.7326/0003-4819-141-7-200410050-00009.
    1. Pippins JR, Gandhi TK, Hamann C, et al. Classifying and predicting errors of inpatient medication reconciliation. J Gen Intern Med. 2008;23(9):1414–1422. doi: 10.1007/s11606-008-0687-9.
    1. Boockvar KS, Liu S, Goldstein N, Nebeker J, Siu A, Fried T. Prescribing discrepancies likely to cause adverse drug events after patient transfer. Qual Saf Health Care. 2009;18(1):32–36. doi: 10.1136/qshc.2007.025957.
    1. Climente-Marti M, Garcia-Manon ER, Artero-Mora A, Jimenez-Torres NV. Potential risk of medication discrepancies and reconciliation errors at admission and discharge from an inpatient medical service. Ann Pharmacother. 2010;44(11):1747–1754. doi: 10.1345/aph.1P184.
    1. Coleman EA, Smith JD, Raha D, Min SJ. Posthospital medication discrepancies: prevalence and contributing factors. Arch Intern Med. 2005;165(16):1842–1847. doi: 10.1001/archinte.165.16.1842.
    1. Cohen MJ, Shaykevich S, Cawthon C, Kripalani S, Paasche-Orlow MK, Schnipper JL. Predictors of medication adherence postdischarge: the impact of patient age, insurance status, and prior adherence. J Hosp Med. 2012;7(6):470–475. doi: 10.1002/jhm.1940.
    1. Cua YM, Kripalani S. Medication use in the transition from hospital to home. Ann Acad Med Singapore. 2008;37(2):136–136.
    1. Gehi AK, Ali S, Na B, Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med. 2007;167(16):1798–1803. doi: 10.1001/archinte.167.16.1798.
    1. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–1841. doi: 10.1001/archinte.166.17.1836.
    1. Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166(17):1842–1847. doi: 10.1001/archinte.166.17.1842.
    1. McDermott MM, Schmitt B, Wallner E. Impact of medication nonadherence on coronary heart disease outcomes. A critical review. Arch Intern Med. 1997;157(17):1921–1929. doi: 10.1001/archinte.1997.00440380023002.
    1. Forster AJ, Clark HD, Menard A, et al. Adverse events among medical patients after discharge from hospital. CMAJ. 2004;170(3):345–349.
    1. Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003;138(3):161–167. doi: 10.7326/0003-4819-138-3-200302040-00007.
    1. Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. Adverse drug events occurring following hospital discharge. J Gen Intern Med. 2005;20(4):317–323. doi: 10.1111/j.1525-1497.2005.30390.x.
    1. Tsilimingras D, Schnipper J, Duke A, et al. Post-discharge adverse events among urban and rural patients of an urban community hospital: a prospective cohort study. J Gen Intern Med. 2015;30(8):1164–1171. doi: 10.1007/s11606-015-3260-3.
    1. Kripalani S, Roumie CL, Dalal AK, et al. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012;157(1):1–10. doi: 10.7326/0003-4819-157-1-201207030-00003.
    1. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163(17):2014–2018. doi: 10.1001/archinte.163.17.2014.
    1. Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166(5):565–571. doi: 10.1001/archinte.166.5.565.
    1. Marien S, Krug B, Spinewine A. Electronic tools to support medication reconciliation: a systematic review. J Am Med Inform Assoc. 2017;24(1):227–240. doi: 10.1093/jamia/ocw068.
    1. Mistry N, Keepanasseril A, Wilczynski NL, et al. Technology-mediated interventions for enhancing medication adherence. J Am Med Inform Assoc. 2015;22(e1):e177–193. doi: 10.1093/jamia/ocu047.
    1. Choi EPH. A pilot study to evaluate the acceptability of using a smart pillbox to enhance medication adherence among primary care patients. Int J Environ Res Public Health. 2019;16(20):3964. doi: 10.3390/ijerph16203964.
    1. Spratt ES, Papa CE, Mueller M, et al. Using technology to improve adherence to HIV medications in transitional age youth: research reviewed, methods tried, lessons learned. J Gen Med (Dover) 2017;1(1):1002.
    1. CFIR Research Team. Center for Clinical Management Research. Consolidated Framework for Implementation Research. 2022. Retrieved July 1, 2022, from .
    1. Rajamani S, Hultman G, Bakker C, Melton GB. The role of organizational culture in health information technology implementations: a scoping review. Learn Health Syst. 2022;6(3):e10299.
    1. Sung M, He J, Zhou Q, et al. Using an integrated framework to investigate the facilitators and barriers of health information technology implementation in noncommunicable disease management: systematic review. J Med Internet Res. 2022;24(7):e37338. doi: 10.2196/37338.
    1. Weinfurt KP, Hernandez AF, Coronado GD, et al. Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH Collaboratory. BMC Med Res Methodol. 2017;17(1):144. doi: 10.1186/s12874-017-0420-7.
    1. Harrison JD, Auerbach AD, Anderson W, et al. Patient stakeholder engagement in research: a narrative review to describe foundational principles and best practice activities. Health Expect. 2019;22(3):307–316. doi: 10.1111/hex.12873.
    1. Wittayanukorn S, Westrick SC, Hansen RA, et al. Evaluation of medication therapy management services for patients with cardiovascular disease in a self-insured employer health plan. J Manag Care Pharm. 2013;19(5):385–395. doi: 10.18553/jmcp.2013.19.5.385.
    1. Reeder B, Demiris G, Marek KD. Older adults' satisfaction with a medication dispensing device in home care. Inform Health Soc Care. 2013;38(3):211–222. doi: 10.3109/17538157.2012.741084.
    1. Dunn KE, Brooner RK, Stoller KB. Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic. J Subst Abuse Treat. 2021;121:108197. doi: 10.1016/j.jsat.2020.108197.
    1. Vaz KKH, Carmody JK, Zhang Y, Denson LA, Hommel KA. Evaluation of a Novel Educational Tool in Adolescents With Inflammatory Bowel Disease: The NEAT Study. J Pediatr Gastroenterol Nutr. 2019;69(5):564–569. doi: 10.1097/MPG.0000000000002431.

Source: PubMed

3
Abonnere